We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Combination of Asciminib+Nilotinib or Asciminib+Dasatinib in Previously Treated Chronic Myeloid Leukemia (CML) Patients: Phase 1 Study Results.
- Authors
DeAngelo, Daniel J.; Mauro, Michael J.; Kim, Dong-Wook; Cortes, Jorge; Réa, Delphine; Hughes, Timothy P.; Minami, Hironobu; Breccia, Massimo; Talpaz, Moshe; Hochhaus, Andreas; Goh, Yeow Tee; Le Coutre, Philipp D.; Sondhi, Manu; Mishra, Kaushal; Hourcade-Potelleret, Florence; Vanasse, Gary; Aimone, Paola; Lang, Fabian
- Publication
Clinical Lymphoma, Myeloma & Leukemia, 2019, Vol 19, pS290
- ISSN
2152-2650
- Publication type
Article
- DOI
10.1016/j.clml.2019.07.236